Although Ranibizumab neutralizes VEGF and interrupts this feedback loop to reduce DME, hyperglycemia-induced damage to retinal vessels could be continued progression in patient with poorer blood sugar control and lead to further retinal vessels occlusion and poorer visual outcomes. Here, VEGFA is linked to Hyperglycemia.